Strongbridge Bio Ord (SBBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SBBP | AMGN | VRTX | REGN | BMY |
| Company | Strongbridge Bio Ord | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.96 | 314.11 | 446.00 | 987.99 | 43.14 |
| High | 2.06 | 316.67 | 446.39 | 995.92 | 43.43 |
| Low | 1.95 | 311.90 | 437.46 | 982.97 | 42.25 |
| Last | 2.00 | 314.85 | 442.00 | 993.95 | 42.27 |
| Change | +0.03 | +0.31 | -3.87 | +6.68 | -1.09 |
| % Change | +1.52% | +0.10% | -0.87% | +0.68% | -2.51% |
| Volume | 684,600 | 1,705,600 | 1,106,700 | 331,600 | 17,576,788 |
| 20-Day Average Volume | 234,660 | 2,833,025 | 1,091,620 | 453,660 | 15,514,120 |
| Previous Close | 1.97 | 314.54 | 445.87 | 987.27 | 43.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.10 | 297.77 | 416.57 | 947.96 | 44.41 |
| 20-Day Raw Stochastic | 13.51% | 86.37% | 89.58% | 98.37% | 0.29% |
| 20-Day Relative Strength | 42.28% | 64.78% | 68.48% | 63.65% | 28.13% |
| Weighted Alpha | -28.48 | +42.60 | +34.49 | +36.74 | -36.20 |
| Today's Opinion | 100% Sell | 72% Buy | 72% Buy | 88% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 72% Buy | 72% Buy | 100% Buy | 100% Sell |
| Last Month's Opinion | 88% Sell | 40% Sell | 8% Buy | 24% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.91% since 09/28/21 | +1.10% since 05/14/24 | +3.13% since 05/14/24 | +0.95% since 05/14/24 | -5.46% since 05/14/24 |
| Low | 1.95 on 10/05/21 | 310.37 on 05/17/24 | 428.62 on 05/15/24 | 966.00 on 05/17/24 | 42.25 on 05/21/24 |
| High | 2.11 on 09/29/21 | 321.44 on 05/15/24 | 447.85 on 05/20/24 | 995.92 on 05/21/24 | 45.17 on 05/15/24 |
| 1-Month | |||||
| %Chg | -10.71% since 09/03/21 | +17.08% since 04/19/24 | +12.10% since 04/19/24 | +10.83% since 04/19/24 | -13.61% since 04/19/24 |
| Low | 1.95 on 10/05/21 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 42.25 on 05/21/24 |
| High | 2.32 on 09/10/21 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 995.92 on 05/21/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | -35.06% since 07/02/21 | +11.07% since 02/21/24 | +5.33% since 02/21/24 | +4.31% since 02/21/24 | -16.97% since 02/21/24 |
| Low | 1.85 on 08/16/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 42.25 on 05/21/24 |
| High | 3.19 on 07/06/21 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -28.06% since 04/05/21 | +19.80% since 11/21/23 | +24.58% since 11/21/23 | +24.43% since 11/21/23 | -12.81% since 11/21/23 |
| Low | 1.85 on 08/16/21 | 260.68 on 04/19/24 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 42.25 on 05/21/24 |
| High | 3.19 on 07/06/21 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 135,658 | 168,730,256 | 115,058,088 | 108,783,320 | 87,895,056 |
| Shares Outstanding, K | 67,829 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 30,730,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -45,080,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 10,040,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -13,240,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 1.59 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 08/05/21 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 11/04/21 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.77 | 29.56 | 26.47 | 41.93 |